The audio of this episode may be broken.
How to fix it?
ABOUT THIS EPISODE
Critical Care Reviews’ Rob Mac Sweeney talks with Prof. Alistair Nichol about ivermectin, one of the latest interventions added to the REMAP-CAP trial. He explains why this intervention is implemented into the trial despite the controversy surrounding the use of ivermectin to treat COVID-19.
English
United States
OTHER EPISODES IN THIS PODCAST
Together with Derek Angus and Tony Gordon, Rob Mac Sweeney dives into the first results of the REMAP-CAP trial and the launch of the first manuscript in JAMA. In this episode we discuss the methodology of the trial and the results of this manuscript.
Critical Care Reviews’ Rob Mac Sweeney talks with professor Steve Webb about the design of REMAP-CAP. In this episode we describe the rationale behind the trial and its origin.
Critical Care Reviews’ Rob Mac Sweeney talks with Dr. Scott Berry about the statistical plan of REMAP-CAP.
Critical Care Reviews’ Rob Mac Sweeney talks with professor Mathias Pletz about pandemics and the COVID-19 pandemic mode of REMAP-CAP.
Critical Care Reviews’ Rob Mac Sweeney talks with professor John Marshall and assistant professor Srinivas Murthy about the interventions in REMAP-CAP.
Disclaimer: The podcast and artwork embedded on this page are from REMAP-CAP, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
EDIT
Thank you for helping to keep the podcast database up to date.
